Table 1 Overview of parameters (median (25th–75th percentiles) and # median (25th percentile)) between coronavirus disease 2019 (COVID-19) patients with and without EBV viremia and non-COVID-19 patients
From: Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19
COVID-19 (n = 18) | COVID-19 EBV negative (n = 4) | COVID-19 EBV positive (n = 14) | Non-COVID-19 (n = 18) | |
|---|---|---|---|---|
Age (years) | 60.5 (52.0–64.5) | 45.5 (43.3–59.0) | 61.5 (53.8–66.8) | 58.8 (47.8–72.3) |
IL-6 (ng/l) | 125.1 (40.5–302.8) | 20.9 (18.0–101.4) | 142.0 (106.0–342.4) | 85.7 (43.6–377.4) |
CRP (mg/dl) | 14.6 (4.3–16.6) | 5.8 (2.2–14.8) | 15.5 (7.7–19.7) | 8.3 (3.7–28.1) |
PCT (µg/l) | 0.3 (0.2–0.8) | 0.2 (0.1–0.4) | 0.4 (0.2–1.1) | 1.3 (0.2–6.8) |
Bilirubin total (mg/dl) | 0.9 (0.4–1.2) | 0.67 (0.4–0.9) | 1.0 (0.4–1.3) | 0.7 (0.5–2.6) |
ASAT (U/l) | 67.5 (33.5–91.8) | 63.0 (18.8–114.0) | 67.5 (33.5–85.8) | 51.0 (38.5–122.3) |
ALAT (U/l) | 49.0 (37.5–80.5) | 73.5 (20.5–185.75) | 49.0 (40.5–72.3) | 56.0 (23.8–194.8) |
GGTP (U/l) | 173.0 (61.5–370.0) | 206.5 (8.8–657.0) | 151.5 (60.3–370.0) | 131.5 (76.5–305.0) |
AP (U/l) | 103.5 (79.0–222.0) | 131.0 (102.3–273.8) | 93.0 (57.3–222.0) | 220.5 (175.5–559.3) |
Amylase (U/l) | 37.0 (24.5–67.0) | 37.0 (22.0)# | 43.0 (23.3–71.8) | 39.0 (15.0–48.0) |
Lipase (U/l) | 43.0 (21.0–75.0) | 26.0 (26.0)# | 47.5 (19.3–74.0) | 30.0 (16.0–66.0) |